Report copyright - The Prix Galien Shareholder Information In September 2008 ... · Improving the Human Condition In September 2008, Alexion’s Soliris® (eculizumab) received the 2008 Prix Galien
Please pass captcha verification before submit form
Please pass captcha verification before submit form